The success of anti-PD-1 with chemotherapy for esophageal squamous cell carcinoma

被引：1
|
作者：
van Laarhoven, Hanneke W. M. [1 ,2 ]
Derks, Sarah [2 ,3 ,4 ]
机构：
[1] Amsterdam UMC Locat Univ Amsterdam, Med Oncol, Meibergdreef 9, Amsterdam, Netherlands
[2] Canc Ctr Amsterdam, Canc Treatment & Qual Life, Amsterdam, Netherlands
[3] Amsterdam UMC Locat Free Univ, Med Oncol, De Boelelaan 1118, Amsterdam, Netherlands
[4] Oncode Inst, Utrecht, Netherlands
来源：
CELL REPORTS MEDICINE | 2023年 / 4卷 / 04期
关键词：
PLUS CHEMOTHERAPY; THERAPY;
D O I：
10.1016/j.xcrm.2023.100990
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
In the ASTRUM-007 randomized double-blind phase III study, Song et al.(1) showed that the combination of PD-1 inhibitors with first-line fluoropyrimidine and platinum-based chemotherapy improves outcomes in PD-L1-overexpressing esophageal squamous cell carcinomas.
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma
    Bo Zhang
    Xi Wang
    Qun Li
    Hongnan Mo
    Xingyuan Wang
    Yan Song
    Jianping Xu
    Tao Qu
    Jing Huang
    Chinese Journal of Cancer Research, 2019, 31 (06) : 910 - 917
  • [2] Efficacy of irinotecan-based chemotherapy after exposure to an anti-PD-1 antibody in patients with advanced esophageal squamous cell carcinoma
    Zhang, Bo
    Wang, Xi
    Li, Qun
    Mo, Hongnan
    Wang, Xingyuan
    Song, Yan
    Xu, Jianping
    Qu, Tao
    Huang, Jing
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (06) : 910 - 917
  • [3] A combined immune prognostic index in esophageal squamous cell carcinoma patients treated with anti-PD-1 therapy
    Ji, Shoujian
    Zhao, Chuanhua
    Liu, Rongrui
    Wang, Yan
    Yang, Qing
    Yang, Hua
    Xu, Jianming
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [4] Cisplatin plus anti-PD-1 antibody enhanced treatment efficacy in advanced esophageal squamous cell carcinoma
    Lin, Wu
    Qian, Jiong
    Wang, Haohao
    Ren, Ling
    Yang, Yan
    Chen, Chuanzhi
    Chen, Xiangliu
    Huang, Yingying
    Liu, Jin
    Xu, Nong
    Teng, Lisong
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (02): : 451 - +
  • [5] Nomograms Predicting Response and Survival of Esophageal Squamous Cell Carcinoma Patients Treated With Anti-PD-1 Therapy
    Wang, Y.
    Nie, S.
    Chen, J.
    Wang, C.
    Zhu, S.
    Hu, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E80 - E80
  • [6] Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives
    Kuo, Hung-Yang
    Guo, Jhe-Cyuan
    Hsu, Chih-Hung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 (02) : 565 - 568
  • [7] Treatment-related lymphopenia impairs the treatment response of anti-PD-1 therapy in esophageal squamous cell carcinoma
    Yin, Tianwen
    Wang, Peiliang
    Yu, Jinming
    Teng, Feifei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 106
  • [8] Advanced Squamous Cell Carcinoma: Complete Remission to Anti-PD-1 Antibody Therapy
    Gellrich, F. F.
    Beissert, S.
    Meier, F.
    AKTUELLE DERMATOLOGIE, 2019, 45 (05) : 233 - 235
  • [9] Anti-PD-1 Therapy is Beneficial for the Survival of Patients with Oral Squamous Cell Carcinoma
    Feng, Liang
    Yin, Ke
    Zhang, Suxin
    Chen, Zhong
    Bao, Yang
    Li, Tianke
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2723 - 2731
  • [10] REDUCED DENDRITIC CELL INFILTRATION IN ANTI-PD-1 RESISTANT HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Saito, Shin
    Shibata, Hirofumi
    Zhou, Liye
    Campbell, Katie
    Egloff, Ann Marie
    Uppaluri, Ravindra
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A555 - A555
12345